Dispensing dentists: Warning notice required on opioid prescription labels

A new state law effective Jan. 1, 2019, requires all dispensers of opioids to prominently display a notice on the prescription label or container of any prescription drug containing an opioid. The notice should be displayed by way of a flag or other notification mechanism attached to the container and must state: “Caution: Opioid. Risk of overdose and addiction.”

This requirement, part of Senate Bill 1109, is one of many that prescribers and dispensers must adhere to in an effort by health care providers, prescribers, pharmacists and other stakeholders to reduce opioid abuse and overdose deaths in California. To learn more about the new requirements and best practices for dental offices, visit cda.org/opioid. To learn more about requirements for prescribers who dispense, see “Controlled Substances: Prescribing and Dispensing” on cda.org/practicesupport.

Related Items

The Dentists Insurance Company has developed a resource to help prescribers follow a new requirement when prescribing Schedule II drugs to minors. Beginning Jan. 1, 2019, before a prescriber issues the first prescription to a minor for a controlled substance containing an opioid, the prescriber must discuss specific information with the minor or the minor’s parent or guardian. The new form, “Consent to Prescribe an Opioid to a Minor,” covers the required discussion items.

Many bills were introduced over the past year to combat the opioid epidemic in California, as CDA previously reported. Here is an overview of CDA-supported legislation in the areas of e-prescribing, informed consent, interstate data sharing and prescription-pad requirements, that Gov. Jerry Brown signed into law in September and how these bills will affect the practice of dentistry.